What is the interstitial variant of Granuloma Annulare (GA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Interstitial granuloma annulare is a rare variant of granuloma annulare that can be effectively managed with UVB/nbUVB/excimer laser therapy as a first-line treatment for patients with generalized disease, given its favorable long-term safety profile and higher response rates compared to other light therapies, as suggested by the most recent and highest quality study 1.

Overview of Interstitial Granuloma Annulare

Interstitial granuloma annulare is characterized by interstitial collagen degeneration and mucin deposition between collagen bundles in the dermis, presenting with flesh-colored to erythematous papules or plaques, often in an annular arrangement. The diagnosis relies on clinicopathological correlation, with a skin biopsy confirming the histological features of the disease.

Treatment Options

Treatment options for interstitial granuloma annulare include:

  • Topical corticosteroids, such as clobetasol 0.05% ointment applied twice daily for 2-4 weeks
  • Intralesional corticosteroid injections, such as triamcinolone acetonide 5-10 mg/ml
  • Topical calcineurin inhibitors, like tacrolimus 0.1% ointment for smaller lesions
  • Systemic therapies, including hydroxychloroquine (200-400 mg daily), dapsone (50-150 mg daily), or phototherapy, for widespread disease

Recommendation

Given the recent evidence from 1, UVB/nbUVB/excimer laser therapy is recommended as a first-line treatment for patients with generalized interstitial granuloma annulare, due to its effectiveness and favorable safety profile. Regular follow-up is recommended, as this condition may occasionally be associated with diabetes mellitus or thyroid disorders in some patients, as noted in 2 and 3.

Pathogenesis and Prognosis

The pathogenesis of interstitial granuloma annulare involves delayed-type hypersensitivity reactions with macrophages and T-lymphocytes causing collagen degradation, though the exact trigger remains unknown 2. Most cases are self-limiting and resolve spontaneously within 2 years, though recurrence is common. The generalized form is more chronic and less responsive to treatment, as mentioned in 3.

References

Research

Light- and laser-based treatments for granuloma annulare: A systematic review.

Photodermatology, photoimmunology & photomedicine, 2022

Research

Granuloma Annulare: A Focused Review of Therapeutic Options.

American journal of clinical dermatology, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.